We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Spoke too soon
Seems to be holding well. a lot of trades today and we are sitting well.
i would be happy to see the price settle here in the short term before we receive any news.
Yes but as I said last week some of the placement of 35 million shares at 1p would be sold in market. Price has not been above 1p since it was announced. But I agree people have sold at a profit. But I feel were move up to the next level shortly.
That’s because the news leaked, people in the know got out, and people who bought in cheap got out.
No deal/no income. Just preliminary research.
Buy and hold if you want to gamble on this. Trade it otherwise
Aim ??? 🙈
Because AIM
Why does the share drop , when you get a positive RNS ???? 🤔
That's very interesting Homer and as you say could be of huge benefit.
This could be a great 12 months if the ducks all line up
Things are coming together here and the dots are being joined. One of the issues being discussed is funding. N4 has already stated that Nanogenics could be funded by third parties. To this end, it is interesting that Dr Simon Newman the Chief Scientific Officer of Nanogenics will take up the same role at the Brain Tumour Charity next month whilst continuing that role at Nanogenics. Interesting because the Brain Tumour Charity is both heavily involved in tumour research itself but more importantly is a major financier of tumour research both directly and through third parties. To have the Nanogenics CSO acting in the interests of Nanogenics/Nuvec could be very advantageous.
I am a new investor here, since early December time, and am really liking the results from the last few RNSs. However, I can't find information regarding the company's plans to commercialise their products. Does anyone know where I can find this? Or just let me know if they haven't communicated anything of sorts I would much appreciate it.
The whole sector moved sharply higher after the AGL re rate.
The rns today is a significant positive.
3.6 m mkt cap offers an attractive risk/reward.
Another good update and it sounds like Nanogenics update to come very soon.
That’s the Aim game. Tip off your mates. Then RNS and not forgetting the hub lastly
The RNS today, summary of key points below, would explain that £55,000 buy on Friday...
* N4P has demonstrated via a series of in vitro experiments that Nuvec® can deliver increased transduction efficacy, when complexed with Adeno-Associated virus 8 ("AAV8").
* This follows on from earlier work where the Company showed that Nuvec® increased transduction efficacy of a standard Adenovirus vector.
* Specifically, Nuvec® was mixed with AAV8 carrying a fluorescent green protein gene and used to transduce human-like liver cells (induced pluripotent cell model). When the viral vector was complexed with Nuvec®, transduction efficacy increased 2.5-fold compared to the AAV8 vector when used on a standalone basis. AAV8 was chosen for investigation as this virus is currently being used for products already in clinical development.
* The number of approvals of new gene therapies and the need for appropriate delivery systems have reached unprecedented highs and demand is growing exponentially.
* The AAV vector market alone (AAV based gene therapy and AAV manufacturing) is projected to grow from USD 1.9 billion in 2022 to USD 11.1 billion by 2035.
* For in vivo gene therapy, the Adenovirus (AV) and Adeno-Associated virus (AAV) are acknowledged as the most used delivery vehicles. However relatively high amounts of AV and AAV are needed to be clinically efficient and this appears directly correlated with adverse events in patients such as unwanted immunogenicity and potential safety implications.
CEO Quote:
"Our work shows that Nuvec® has the potential to reduce the amount of AV and AAV needed and thus decrease both the cost of goods and immunogenicity associated with using these viral vectors. We believe this will be a major focus of the pharma/biotech industry as these viral vector delivery systems are further investigated.
"This work is running in parallel to our ongoing oral and dual loading work as well as the Nanogenics' Glaucoma product, an update on which will follow soon."
In a nutshell, yet more encouraging news from N4P....
Good luck, Brighty
dodgy ****s
Price shoots up Friday - positive rns on Monday (talk about leaky) Not complaining though. Should drop to sub 1p by the end of week.
Good week for N4P. Still has a piddly valuation...
You would think there will be an update on the Nanogenics side of the business (recent acquisition) quite soon.
Apologies i tried to paste the TG grp info and failed...
Search for it on Twitter using #N4P and you'll find it.
nuvec®, has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.
https://**************sxsr6e16xrifskcgww-mkw
Yes, 4.23M at 1.3p.
I would suggest that for someone to buy £55K’s worth of stock in a tiny AIM Biotechnology Company would be a decision made with a high degree of knowledge and information.
This could get interesting rather quickly.
Is there a link for it pls?
Yep
Is the group still going?
Nice conviction buy 💪
Wow nice buy. 👏